Evolent Health, Inc. 4
4 · Evolent Health, Inc. · Filed Jun 14, 2017
Insider Transaction Report
Form 4
McGrane Nicholas
Chief Financial Officer
Transactions
- Sale
Class A Common Stock
2017-06-12$25.40/sh−100$2,540→ 31,589 total - Exercise/Conversion
Class A Common Stock Option (right to buy)
2017-06-12−1,667→ 211,285 totalExercise: $3.84Exp: 2024-10-22→ Class A Common Stock (1,667 underlying) - Exercise/Conversion
Class A Common Stock
2017-06-12$3.84/sh+1,667$6,401→ 33,256 total - Sale
Class A Common Stock
2017-06-12$24.53/sh−1,567$38,439→ 31,689 total
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016.
- [F2]Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F3]The price reported on Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.05-$24.85, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The Class A Common Stock Options exercised vested on February 1, 2016.